MedPath

The effect of DASH diet in subjects with metabolic syndrome

Phase 3
Conditions
Metabolic syndrome.
Metabolic syndrome
E88.81
Registration Number
IRCT20180201038585N12
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 30-60 years
Diagnosis of Metabolic Syndrome based on IDF criteria
Sign of informed written consent

Exclusion Criteria

Pregnancy and lactation
Hereditary hemochromatosis
History of gingival or gastroplasty bypass surgery
Use of hepatotoxic drugs such as calcium channel blocker and high doses of synthetic estrogens
Patients with hypothyroidism
Cushing syndrome
Kidney failure and kidney stone
Cardiovascular disease
History of hepatitis B and C
Wilson disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diastolic Blood Pressure. Timepoint: Before intervention and 12 weeks after the intervention. Method of measurement: Sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath